News and press

Filter by:

7th February 2012

Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.

To examine the efficacy and tolerability of rosuvastatin 5 mg at daily and non-daily dosing regimens.

Claire Meek , Professor Anthony S. Wierzbicki, Christina Jewkes, Patrick J Twomey, Martin A Crook, Alan Jones, Adie Viljoen

20th January 2012

Novel management of anticoagulant resistant thrombotic hypodysfibrinogenaemia.

Individuals with hypodysfibrinogenaemia and recurrent thrombosis are rarely encountered and there is no consensus regarding long-term management.

Rea C, Professor Beverley Hunt

11th January 2012

Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.

The antiphospholipid syndrome (APS) is the association of thrombosis and recurrent pregnancy loss and/or pregnancy morbidity with persistent antiphospholipid antibodies (aPL).

K. A. Breen , P. Seed, K. Parmar , G. W. Moore, S. E. Stuart-Smith, Professor Beverley Hunt

1st January 2012

Effects of mitotane on exogenous and endogenous steroid metabolism

Lea Ghataore , Indira Chakraborti, Simon Aylwin, Klaus-Martin Schulte

31st December 2011

The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial.

Hypertriglyceridemia is common in patients with HIV treated with highly active antiretroviral therapy (HAART).

Barry S. Peters , Professor Anthony S. Wierzbicki, Graeme Moyle, Devaki Nair, Norbert Brockmeyer

21st December 2011

Steroids excreted in urine by neonates with 21-hydroxylase deficiency. 2. Characterization, using GC-MS and GC-MS/MS, of pregnanes and pregnenes with an oxo- group on the A- or B-ring

Sofia Christakoudi, David A. Cowan

14th December 2011

A Missense Mutation in the Human Cytochrome b5 Gene causes 46,XY Disorder of Sex Development due to True Isolated 17,20 Lyase Deficiency

Jan Idkowiak, Tabitha Randell, Vivek Dhir, Pushpa Patel, Cedric H. L. Shackleton, Nils Krone, Wiebke Arlt

7th December 2011

Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency

Nils Krone, Nicole Reisch, Jan Idkowiak, Vivek Dhir, Hannah E. Ivison, Beverly A. Hughes, Ian T. Rose, Donna M. O'Neil, Raymon Vijzelaar, Matthew J. Smith, Fiona MacDonald, Trevor R. Cole , Nicolai Adolphs, John S. Barton, Edward M. Blair, Stephen R. Braddock, Felicity Collins, Deborah L. Cragun, Mehul T. Dattani, Ruth Day, Shelley Dougan, Miriam Feist, Michael E. Gottschalk, John W. Gregory, Michaela Haim, Rachel Harrison, Ann Haskins Olney, Berthold P. Hauffa, Peter C. Hindmarsh, Robert J. Hopkin, Petr E. Jira, Marlies Kempers, Michiel N. Kerstens, Mohamed M. Khalifa, Birgit Köhler, Dominique Maiter, Shelly Nielsen, Stephen M. O'Riordan, Christian L. Roth, Kate P. Shane, Martin Silink, Nike M. M. L. Stikkelbroeck, Elizabeth Sweeney, Maria Szarras-Czapnik, John R. Waterson, Lori Williamson, Michaela F. Hartmann, Stefan A. Wudy, Ewa M. Malunowicz, Cedric H. L. Shackleton, Wiebke Arlt

11th November 2011

The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding.

Recent interest in transfusion management of trauma patients has heightened expectation in the role of blood component therapy in improving patient outcome.

Stanworth SJ, Professor Beverley Hunt

3rd November 2011

The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia

Coagulopathy occurs in most patients with (APML) and is life-threatening; therefore prompt diagnosis and recognition of any coagulation defect is imperative.

Karen A. Breen, David Grimwade, Professor Beverley Hunt

Last updated: 23/09/2022

Search form

News and press

eMail alerts and news

Site details

Search form

News and press

Share this page

eMail alerts and news

Follow us

Site details